Review



human ifn gamma elispotpro kit alp  (Mabtech Inc)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 86
      Buy from Supplier

    Structured Review

    Mabtech Inc human ifn gamma elispotpro kit alp
    Human Ifn Gamma Elispotpro Kit Alp, supplied by Mabtech Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+ifn+gamma+elispotpro+kit+alp/pm41520688-40-5-4?v=Mabtech+Inc
    Average 86 stars, based on 1 article reviews
    human ifn gamma elispotpro kit alp - by Bioz Stars, 2026-07
    86/100 stars

    Images



    Similar Products

    human ifn gamma elispotpro kit alp  (Mabtech Inc)
    86
    Mabtech Inc human ifn gamma elispotpro kit alp
    Human Ifn Gamma Elispotpro Kit Alp, supplied by Mabtech Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+ifn+gamma+elispotpro+kit+alp/pm41520688-40-5-4?v=Mabtech+Inc
    Average 86 stars, based on 1 article reviews
    human ifn gamma elispotpro kit alp - by Bioz Stars, 2026-07
    86/100 stars
    		  Buy from Supplier
    human ifn-γ elispotpro kit (alp)  (Mabtech Inc)
    90
    Mabtech Inc human ifn-γ elispotpro kit (alp)
    (A) Representative ELISpots of PBMCs transfected with S, P1, P2, no <t>mRNA</t> (mock) or PBMCs treated with ConA (positive control) from participant 6 (responder) and 26 (non-responder). The number of spot counts per well was indicated. (B) Fold increase <t>of</t> <t>IFN-γ</t> spot counts of PBMCs after transfection with S, P1, or P2 mRNA relative to the mock treatment from 34 participants. Participants having a fold increase less than 2 (cutoff value) were classified as non-responders. (C) UpSet plot showing the number of participants having T-cell responses to S, P1 or P2 mRNA, as well as the overlap between such conditions. Percentages of (D) CD4 + IFN-γ + T cells and (E) CD8 + IFN-γ + T cells measured by flowcytometry from 34 participants, grouped into <1 month, >1 month, and unknown, after transfection with S, P1, or P2 mRNA. One-way ANOVA test was performed to compare the frequencies of CD4 + IFN-γ + T cells and CD8 + IFN-γ + T cells across different groups; *p < 0.05; **p < 0.01; ***p < 0.001.
    Human Ifn γ Elispotpro Kit (Alp), supplied by Mabtech Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+ifn+gamma+elispotpro+kit+alp/pmc10308627-76-9-15?v=Mabtech+Inc
    Average 90 stars, based on 1 article reviews
    human ifn-γ elispotpro kit (alp) - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    human ifn-gamma elispotpro kit (alp)  (Mabtech Inc)
    90
    Mabtech Inc human ifn-gamma elispotpro kit (alp)
    (A) Representative ELISpots of PBMCs transfected with S, P1, P2, no <t>mRNA</t> (mock) or PBMCs treated with ConA (positive control) from participant 6 (responder) and 26 (non-responder). The number of spot counts per well was indicated. (B) Fold increase <t>of</t> <t>IFN-γ</t> spot counts of PBMCs after transfection with S, P1, or P2 mRNA relative to the mock treatment from 34 participants. Participants having a fold increase less than 2 (cutoff value) were classified as non-responders. (C) UpSet plot showing the number of participants having T-cell responses to S, P1 or P2 mRNA, as well as the overlap between such conditions. Percentages of (D) CD4 + IFN-γ + T cells and (E) CD8 + IFN-γ + T cells measured by flowcytometry from 34 participants, grouped into <1 month, >1 month, and unknown, after transfection with S, P1, or P2 mRNA. One-way ANOVA test was performed to compare the frequencies of CD4 + IFN-γ + T cells and CD8 + IFN-γ + T cells across different groups; *p < 0.05; **p < 0.01; ***p < 0.001.
    Human Ifn Gamma Elispotpro Kit (Alp), supplied by Mabtech Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+ifn+gamma+elispotpro+kit+alp/pmc09707775-254-39-45?v=Mabtech+Inc
    Average 90 stars, based on 1 article reviews
    human ifn-gamma elispotpro kit (alp) - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier
    anti-ifn-γ msip white plates human ifng elispotpro kit (alp)  (Mabtech Inc)
    90
    Mabtech Inc anti-ifn-γ msip white plates human ifng elispotpro kit (alp)
    (A) Representative ELISpots of PBMCs transfected with S, P1, P2, no <t>mRNA</t> (mock) or PBMCs treated with ConA (positive control) from participant 6 (responder) and 26 (non-responder). The number of spot counts per well was indicated. (B) Fold increase <t>of</t> <t>IFN-γ</t> spot counts of PBMCs after transfection with S, P1, or P2 mRNA relative to the mock treatment from 34 participants. Participants having a fold increase less than 2 (cutoff value) were classified as non-responders. (C) UpSet plot showing the number of participants having T-cell responses to S, P1 or P2 mRNA, as well as the overlap between such conditions. Percentages of (D) CD4 + IFN-γ + T cells and (E) CD8 + IFN-γ + T cells measured by flowcytometry from 34 participants, grouped into <1 month, >1 month, and unknown, after transfection with S, P1, or P2 mRNA. One-way ANOVA test was performed to compare the frequencies of CD4 + IFN-γ + T cells and CD8 + IFN-γ + T cells across different groups; *p < 0.05; **p < 0.01; ***p < 0.001.
    Anti Ifn γ Msip White Plates Human Ifng Elispotpro Kit (Alp), supplied by Mabtech Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/human+ifn+gamma+elispotpro+kit+alp/pmc09295597-66-11-21?v=Mabtech+Inc
    Average 90 stars, based on 1 article reviews
    anti-ifn-γ msip white plates human ifng elispotpro kit (alp) - by Bioz Stars, 2026-07
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    (A) Representative ELISpots of PBMCs transfected with S, P1, P2, no mRNA (mock) or PBMCs treated with ConA (positive control) from participant 6 (responder) and 26 (non-responder). The number of spot counts per well was indicated. (B) Fold increase of IFN-γ spot counts of PBMCs after transfection with S, P1, or P2 mRNA relative to the mock treatment from 34 participants. Participants having a fold increase less than 2 (cutoff value) were classified as non-responders. (C) UpSet plot showing the number of participants having T-cell responses to S, P1 or P2 mRNA, as well as the overlap between such conditions. Percentages of (D) CD4 + IFN-γ + T cells and (E) CD8 + IFN-γ + T cells measured by flowcytometry from 34 participants, grouped into <1 month, >1 month, and unknown, after transfection with S, P1, or P2 mRNA. One-way ANOVA test was performed to compare the frequencies of CD4 + IFN-γ + T cells and CD8 + IFN-γ + T cells across different groups; *p < 0.05; **p < 0.01; ***p < 0.001.

    Journal: Future Virology

    Article Title: Design and generation of mRNAs encoding conserved regions of SARS-CoV-2 ORF1ab for T cell-mediated immune activation

    doi: 10.2217/fvl-2023-0066

    Figure Lengend Snippet: (A) Representative ELISpots of PBMCs transfected with S, P1, P2, no mRNA (mock) or PBMCs treated with ConA (positive control) from participant 6 (responder) and 26 (non-responder). The number of spot counts per well was indicated. (B) Fold increase of IFN-γ spot counts of PBMCs after transfection with S, P1, or P2 mRNA relative to the mock treatment from 34 participants. Participants having a fold increase less than 2 (cutoff value) were classified as non-responders. (C) UpSet plot showing the number of participants having T-cell responses to S, P1 or P2 mRNA, as well as the overlap between such conditions. Percentages of (D) CD4 + IFN-γ + T cells and (E) CD8 + IFN-γ + T cells measured by flowcytometry from 34 participants, grouped into <1 month, >1 month, and unknown, after transfection with S, P1, or P2 mRNA. One-way ANOVA test was performed to compare the frequencies of CD4 + IFN-γ + T cells and CD8 + IFN-γ + T cells across different groups; *p < 0.05; **p < 0.01; ***p < 0.001.

    Article Snippet: To evaluate the T-cell response when stimulated with the mRNA, Human IFN-γ ELISpotPRO kit (ALP) (Mabtech, 3420-2AST-2, Nacka Strand, Sweden) was used to measure IFN-γ secretion by PBMCs, following the manufacturer's instruction.

    Techniques: Transfection, Positive Control